您当前的位置:
首页 >
文章列表页 >
KAP investigation and analysis of drug use safety risk of Sanjin tablets
更新时间:2023-02-22
    • KAP investigation and analysis of drug use safety risk of Sanjin tablets

    • ZHONGGUO YAOFANG   Vol. 33, Issue 23, Pages: 2908-2912(2022)
    • DOI:10.6039/j.issn.1001-0408.2022.23.17    

      CLC: R969.3
    • Published:15 December 2022

      Received:22 June 2022

      Revised:09 October 2022

    扫 描 看 全 文

  • YANG Yalei,LI Chunxiao,LING Xiao,et al.KAP investigation and analysis of drug use safety risk of Sanjin tablets[J].ZHONGGUO YAOFANG,2022,33(23):2908-2912. DOI: 10.6039/j.issn.1001-0408.2022.23.17.

  •  
  •  

0

Views

2

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Application and evaluation of management mode for the use of antimicrobial drugs in county-level medical communities led by anti-infective clinical pharmacists
Expert consensus on comprehensive clinical evaluation of antidepressant drugs
Effect of posaconazole combined with proton pump inhibitors on blood concentrations and invasive fungal infection in patients with malignant hematological disorders
Clinical comprehensive evaluation of Chinese patent medicine for the treatment of chronic hepatitis B
Comparison of two analysis methods of opioid consumption sum in medical institutions

Related Author

DENG Xiaoqin
ZHAO Chi
LI Zhaohong
YAN Hongyan
SHEN Dongfang
TAN Helang
JIANG Mingzhong
DENG Nanjun

Related Institution

Dept. of Pharmacy, Zhongxian People’s Hospital of Chongqing, Chongqing Zhongxian
Psychic Health Research Institute, the Second Xiangya Hospital of Central South University
Shanghai Mental Health Center Affiliated to Shanghai Jiao Tong University School of Medicine/National Center for Mental Disorder
Peking University Sixth Hospital/National Clinical Research Center for Psychiatric and Mental Disorders
Dept. of Hematology, the First Hosptial of Hebei Medical University
0